Geriatric CDS Tool Boosts Safe Prescribing in the ED
METHODOLOGY:
In this retrospective study, the researchers analyzed 6745 ED orders during 5814 patient encounters (median age, 72 years; approximately 70% White and 22.7% Black) and 1440 discharge prescriptions for PIMs in adults aged 65 years or older between August and December 2021.
In October 2021, a geriatric CDS system was implemented into the EHR, which provided dosing recommendations and suggested alternative medications for 12 high-risk PIMs.
The primary outcome was adherence to CDS recommendations. Secondary outcomes included the use of the CDS panel and adherence rates by medication type.
TAKEAWAY:
Following the implementation of CDS, the proportion of targeted PIMs adherent to geriatric recommendations increased from 52% to 71% for ED orders and from 0.5% to 31.7% for discharge prescriptions.
Utilization of the geriatric CDS order panel reached 62.1% for ED orders and 36.7% for discharge prescriptions.
Among orders placed through the geriatric CDS panels, 90% of ED orders and 80.4% of discharge prescriptions adhered to geriatric CDS recommendations.
Adherence to geriatric CDS improved for most ED orders, except for a few drugs such as diphenhydramine, indomethacin, oral and intravenous ketorolac, and oral lorazepam.
IN PRACTICE:
"Geriatric clinical decision support implemented in the ED for targeted potentially inappropriate medications significantly increased the proportion of ED orders and discharge prescriptions adherent to geriatric drug therapy recommendations," the authors wrote. "As the volume of older patients in the ED increases, electronic health record–based clinical decision support can allow for care that is both better tailored and safer for this vulnerable population," they added.
SOURCE:
The study was led by Gina A. Elder, PharmD, Cleveland Clinic, Cleveland. It was published online on May 13 in Academic Emergency Medicine .
LIMITATIONS:
Prescriber behavior changes and shared decision-making with patients could have influenced the findings. Data on important patient covariates such as ethnicity, preexisting dementia history, primary language, and rurality were not collected. Differences in patient volumes and site-level variations were not considered.
DISCLOSURES:
The authors did not report any funding information and reported no relevant conflicts of interest.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
3 minutes ago
- Medscape
Monthly Ivermectin Cuts Malaria Incidence in Endemic Area
TOPLINE: Monthly administration of ivermectin for 3 consecutive months at the beginning of the short rainy season was associated with a lower incidence of malaria than albendazole in an area with high coverage and use of bed nets, with no safety concerns identified during the trial. METHODOLOGY: Malaria remains a significant global health issue, and rising mosquito resistance to insecticides undermines control measures. As a result, ivermectin, a broad-spectrum anti-parasitic drug, has gained interest as a potential candidate to reduce malaria transmission. Researchers conducted a cluster-randomized trial in Kwale, Kenya, to evaluate the efficacy and safety of mass ivermectin administration at the start of the short rainy season (October-December) for malaria transmission control. A total of 84 clusters comprising 28,932 participants — including all male and nonpregnant female residents weighing more than 15 kg and without severe illness — were identified. They were randomly allocated to receive either ivermectin (400 μg/kg body weight) or albendazole (400 mg) once monthly for 3 consecutive months. Efficacy was assessed in 2871 children aged 5-15 years. The primary outcome was the cumulative incidence of malaria in children. Safety was assessed in all participants, with children followed up prospectively for 6 months after the first round of mass drug administration. TAKEAWAY: The administration of ivermectin reduced malaria incidence by 26% compared with albendazole (2.20 vs 2.66 infections per child-year at risk; adjusted incidence rate ratio [IRR], 0.74; P = .02). A secondary analysis showed that the time to the first infection was 22.5% longer with ivermectin than with albendazole (120 vs 93 days). The incidence of adverse events per 100 treated participants was higher with ivermectin (6.19) than albendazole (3.75). Serious adverse events were rare — 0.023 and 0.037 per 100 treated participants in the ivermectin and albendazole groups, respectively (IRR 0.63; P = .46). IN PRACTICE: 'This trial provides evidence to support the use of ivermectin as a complementary strategy for malaria control and prevention in areas where malaria is mesoendemic and transmission is perennial,' the authors wrote. SOURCE: The study was led by Carlos Chaccour, MD, PhD, ISGlobal in Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas in Madrid, and the Navarra Center for International Development, Universidad de Navarra in Pamplona, Spain. It was published online on July 23, 2025, in The New England Journal of Medicine. LIMITATIONS: The study was limited by the absence of data on the incidence of malaria before the intervention, potential underestimation of ivermectin's effect due to more frequent artemether-lumefantrine use in the albendazole group, and higher treatment coverage in albendazole clusters, probably because of a lower pill burden with albendazole than with weight-based ivermectin dosing. DISCLOSURES: The study was supported by the BOHEMIA grant from Unitaid. Additionally, ISGlobal received support from the Spanish Ministry of Science and the Generalitat de Catalunya. The authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Yahoo
20 minutes ago
- Yahoo
Is Magnesium in Skin Care Really Worth It? Dermatologists Weigh In
Magnesium is having a bit of a moment. Like vitamin C before it, magnesium has managed to be both an essential mineral that we all need to live and a trendy ingredient popping up in viral TikTok recipes. Now, it's in skin care. "I never really thought of magnesium as something specific for skin because it's not just for skin," dermatologist Dr. Shasa Hu, cosmetic director of the skin of color division at the University of Miami Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, tells While magnesium can help maintain the function of your skin's protective barrier, Hu says, it's also necessary for many bodily functions, including muscular function, brain health, glucose metabolism and energy processing in your cells. These days, you might see magnesium marketed in products alongside other skin-care ingredients including peptides and antioxidants. It's been included in products with supposed anti-aging benefits as well as "calming" moisturizers. "It's not like we haven't recognized magnesium as being important," Hu adds, "it's just surprising that we're all talking about it now." So, how much of magnesium's potential skin benefits are hype versus the real deal? Here's what the experts say. Magnesium Benefits in Skin Care "There's not a ton of really high-quality studies on magnesium (in skin care), but it certainly has some data to support its use," Dr. Shari Lipner, associate professor of clinical dermatology at New York-Presbyterian Hospital/Weill Cornell Medical Center, tells Primarily, magnesium is thought to support the functions of the skin barrier, Lipner says. When it's working properly, the skin barrier both keeps water in the skin, ensuring it stays hydrated, as well as protecting the skin by keeping potential pathogens out. These functions in combination with magnesium's possible anti-inflammatory properties "could be beneficial in diseases like eczema and psoriasis," Lipner explains. Conditions like these are characterized by a damaged or dysfunctional skin barrier, which leads to dry skin and scaling. In fact, there is research to suggest that Dead Sea soaking can be helpful for people with psoriasis, Hu says. "They have compromised skin barrier, so they have (much) higher absorption," she explains, which can even increase the magnesium levels in their blood. However, don't expect to get the same level of relief at home. The skin-care products you see with magnesium don't have anywhere near the same amount of the mineral, and those with an intact skin barrier aren't likely to get much penetration, Hu says. Additionally, magnesium may confer some anti-aging benefits by assisting with the synthesis of collagen and elastin, Lipner says. "It can also help regulate oil production from the sebaceous glands," she adds, which could be helpful for those with oil, acne-prone skin. Do Magnesium Lotions Actually Work? Some magnesium creams, lotions and sprays are advertised as being "transdermal," meaning they're designed to penetrate the skin into the bloodstream. But does that mean you can use magnesium lotion instead of an oral supplement? Not really, integrative pharmacist Emlah Tubuo, owner of Powell Pharmacy and member of the American Pharmacists Association, tells "If you're looking for magnesium to actually rectify a deficiency, the go-to will not be topical magnesium," Tubuo explains, so it's not a replacement for an oral magnesium supplement. But, for something like muscle soreness, she may steer folks towards a mineral soak or epsom salt bath, both of which are typically forms of magnesium. "There's some research that shows that it will penetrate through the hair follicle and through sweat glands," she says, "but it's not significant enough to make a change in the serum levels of magnesium." That's because it's actually quite a challenge to get magnesium into the bloodstream. For one thing, the formulation needs to be lipophilic, meaning it's fat-soluble, to get through the top layer of skin, Hu explains. And it also needs to be a small enough molecule to make it through, she added. So far, research shows that topical magnesium just isn't absorbed effectively enough to make a major difference, Hu says. Magnesium Risks Magnesium is an essential mineral, and topical magnesium products are generally safe for most people. But, the experts say, there are some who should take caution with any magnesium product — including skin care. The balance of magnesium in your body is regulated by your kidneys, Tubuo says. "So, if your provider has ever told you that there's something wrong with your kidneys, or they are watching your kidneys, don't go near magnesium supplementation," she warns. If you have any kidney issues, it's going to be much harder for your body to properly excrete excess magnesium, Tubuo explains. That's true for oral magnesium supplements, and you should also err on the side of caution and skip topical magnesium, too, Lipner says. This article was originally published on
Yahoo
21 minutes ago
- Yahoo
Snail's regenerating eye may unlock cure for human blindness
On August 6, 2025, researchers in California revealed how freshwater apple snails can regrow lost eyes. The study, published in Nature Communications, shows the process mirrors human eye anatomy and genetics. Scientists hope isolating the key genes could one day enable humans to regenerate damaged eyes.
